A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

NCT00531817 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

619

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Tocilizumab
DRUG: Placebo
DRUG: Permitted DMARDs

Sponsor

Hoffmann-La Roche